The neurobiology of opiate motivation

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 10, 2012, Pages

  Ting A Kee, Ryan ^a   van der Kooy, Derek ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; G PROTEIN COUPLED RECEPTOR; MU OPIATE RECEPTOR; OPIATE; DOPAMINE;

ALLODYNIA; ARTICLE; BEHAVIOR; CAENORHABDITIS ELEGANS; DEPOLARIZATION; DOWN REGULATION; ELECTROPHYSIOLOGY; EXCITATION; HUMAN; INTRACELLULAR SIGNALING; ION TRANSPORT; NERVE CELL NETWORK; NEUROBIOLOGY; NUCLEUS ACCUMBENS; OPIATE ADDICTION; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; REINFORCEMENT; SIGNAL TRANSDUCTION; VENTRAL TEGMENTUM; ANIMAL; DRUG EFFECT; METABOLISM; MOTIVATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; DOPAMINE; HUMANS; MOTIVATION; OPIATE ALKALOIDS; OPIOID-RELATED DISORDERS; RECEPTORS, GABA; SIGNAL TRANSDUCTION; VENTRAL TEGMENTAL AREA;

EID: 84875622656     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a012096     Document Type: Article

References (125)

1. Amalric M, Koob GF. 1985. Low doses of methylnaloxonium in the nucleus accumbens antagonize hyperactivity induced by heroin in the rat. Pharmacol Biochem Behav 23: 411-415.
2. Asiedu M, Ossipov MH, Kaila K, Price TJ. 2010. Acetazolamide and midazolam act synergistically to inhibit neuropathic pain. Pain 148: 302-308.
3. Auger AP, Perrot-Sinal TS, McCarthy MM. 2001. Excitatory versus inhibitory GABA as a divergence point in steroid-mediated sexual differentiation of the brain. Proc Natl Acad Sci 98: 8059-8064.
4. Balcita-Pedicino JJ, Omelchenko N, Bell R, Sesack SR. 2011. The inhibitory influence of the lateral habenula on midbrain dopamine cells: Ultrastructural evidence for indirect mediation via the rostromedial mesopontine tegmental nucleus. J Comp Neurol 519: 1143-1164.
5. Bechara A, van der Kooy D. 1992. A single brain stem substrate mediates the motivational effects of both opiates and food in nondeprived rats but not in deprived rats. Behav Neurosci 106: 351-363.
6. Beg AA, Jorgensen EM. 2003. EXP-1 is an excitatory GABA-gated cation channel. Nat Neurosci 6: 1145-1152.
7. Ben-Ari Y. 2002. Excitatory actions of GABA during development: The nature of the nurture. Nat Rev Neurosci 3: 728-739.
8. Berglind WJ, See RE, Fuchs RA, Ghee SM, Whitfield TWJ, Miller SW, McGinty JF. 2007. A BDNF infusion into the medial prefrontal cortex suppresses cocaine seeking in rats. Eur J Neurosci 26: 757-766.
9. Blaha CD, Allen LF, Das S, Inglis WL, Latimer MP, Vincent SR, Winn P. 1996. Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine tegmental nucleus-lesioned, and laterodorsal tegmental nucleus-lesioned rats. J Neurosci 16: 714-722.
10. Bozarth MA, Wise RA. 1981. Heroin reward is dependent on a dopaminergic substrate. Life Sci 29: 1881-1886.
11. Bozarth MA, Wise RA. 1984. Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science 224: 516-517.
12. Areceptor surface expression. Eur J Neurosci 13: 1320-1328.
13. Carr DB, Sesack SR. 2000. Projections from the rat prefrontal cortex to the ventral tegmental area: Target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J Neurosci 20: 3864-3873.
14. Chelib M, Johnson GAR. 1999. The "ABC" of GABA receptors: A brief review. Clin Exp Pharmacol Physiol 26: 937-940.
15. Cherubini E, Rovira C, Gaiarsa JL, Corradetti R, Ben-Ari Y. 1990. GABA mediated excitation in immature rat CA3 hippocampal neurons. Int J Dev Neurosci 8: 481-490.
16. Cherubini E, Gaiarsa JL, Ben-Ari Y. 1991. GABA: An excitatory transmitter in early postnatal life. Trends Neurosci 14: 515-519.
17. Churchill L, Dilts R, Kalivas P. 1992. Autoradiographic localization of γ-aminobutyric acid-A receptors within the ventral tegmental area. Neurochem Res 17: 101-106.
18. Coull JAM, Boudreau D, Bachand K, Prescott SA, Nault F, Sik A, De Koninck P, De Koninck Y. 2003. Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature 424: 938-942.
19. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, De Koninck Y. 2005. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438: 1017-1021.
20. Di Chiara G, Imperato A. 1985. Ethanol preferentially stimulates dopamine release in the nucleus accumbens of freely moving rats. Eur J Pharmacol 115: 131-132.
21. Dilts R, Kalivas PW. 1989. Autoradiographic localization of μ-opioid and neurotensin receptors within the mesolimbic dopamine system. Brain Res 488: 311-327.
22. Dobi A, Margolis EB, Wang HL, Harvey BK, Morales M. 2010. Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons. J Neurosci 30: 218-229.
23. Dockstader CL, Rubinstein M, Grandy DK, Low MJ, van der Kooy D. 2001. The D2 receptor is critical in mediating opiate motivation only in opiate-dependent and withdrawn mice. Eur J Neurosci 13: 995-1001.
24. Ford B, Holmes CJ, Mainville L, Jones BE. 1995. GABAergic neurons in the rat pontomesencephalic tegmentum: Codistribution with cholinergic and other tegmental neurons projecting to the posterior lateral hypothalamus. J Comp Neurol 363: 177-196.
25. Ford CP, Mark GP, Williams JT. 2006. Properties and opioid inhibition of mesolimbic dopamine neurons vary according to target location. J Neurosci 26: 2788-2797.
26. A-receptor subtypes during postnatal development: An immunohistochemical study. J Neurosci 14: 5302-5324.
27. Garzon M, Pickel VM. 2001. Plasmalemmal μ-opioid receptor distribution mainly in nondopaminergic neurons in the rat ventral tegmental area. Synapse 41: 311-328.
28. Garzon M, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. 1999. Cholinergic axon terminals in the ventral tegmental area target a subpopulation of neurons expressing low levels of the dopamine transporter. J Comp Neurol 410: 197-210.
29. Gruber SA, Silveri MM, Yurgelun-Todd DA. 2007. Neuropsychological consequences of opiate use. Neuropsychol Rev 17: 299-315.
30. Gysling K, Wang RY. 1983. Morphine-induced activation of A10 dopamine neurons in the rat. Brain Res 277: 119-127.
31. Hall FS, Drgonova J, Goeb M, Uhl GR. 2003. Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice. Neuropsychopharm 28: 1485-1490.
32. Hevers W, Luddens H. 1998. The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes. Mol Neurobiol 18: 35-86.
33. Hnasko TS, Sotak BN, Palmiter RD. 2005. Morphine reward in dopamine-deficient mice. Nature 438: 854-857.
34. Hubner CA, Stein V, Hermans-Borgmeyer I, Meyer T, Ballanyi K, Jentsch TJ. 2001. Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition. Neuron 30: 515-524.
35. A receptor blockade in the anterior ventral tegmental area increases extracellular levels of dopamine in the nucleus accumbens of rats. J Neurochem 69: 137-143.
36. Ikemoto S, Murphy JM, McBride WJ. 1998. Regional differences within the rat ventral tegmental area for muscimol self-infusions. Pharmacol Biochem Behav 61: 87-92.
37. Jhou TC, Fields HL, Baxter MG, Saper CB, Holland PC. 2009a. The rostromedial tegmental nucleus (RMTg), a GABAergic afferent to midbrain dopamine neurons, encodes aversive stimuli and inhibits motor responses. Neuron 61: 786-800.
38. Jhou TC, Geisler S, Marinelli M, Degarmo BA, Zahm DS. 2009b. The mesopontine rostromedial tegmental nucleus: A structure targeted by the lateral habenula that projects to the ventral tegmental area of Tsai and substantia nigra compacta. J Comp Neurol 513: 566-596.
39. Johnson SW, North RA. 1992. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12: 483-488.
40. A receptor pharmacology. Pharmacol Ther 69: 173-198.
41. Kahle KT, Staley KJ, Nahed BV, Gamba G, Hebert SC, Lifton RP, Mount DB. 2008. Roles of the cation-chloride cotransporters in neurological disease. Nat Clin Pract Neurol 4: 490-503.
42. A receptor channel function in the nervous system. Prog Neurobiol 42: 489-537.
43. A receptor-mediated IPSPs of rat neocortical neurones. J Physiol 464: 273-289.
44. + transient. J Neurosci 17: 7662-7672.
45. Kalant H. 1997. Opium revisited: A brief review of its nature, composition, non-medical use and relative risks. Addiction 92: 267-277.
46. Kalivas PW. 1993. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Rev 18: 75-113.
47. Kalivas PW, Alesdatter JE. 1993. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J Pharmacol Exp Ther 267: 486-495.
48. Kalivas PW, Duffy P, Eberhardt H. 1990. Modulation of A10 dopamine neurons by γ-aminobutyric acid agonists. J Pharmacol Exp Ther 253: 858-866.
49. Kanjhan R. 1995. Opioids and pain. Clin Exp Pharmacol Physiol 22: 397-403.
50. Kida E, Palminiello S, Golabek AA, Walus M, Wierzba-Bobrowicz T, Rabe A, Albertini G, Wisniewski KE. 2006. Carbonic anhydrase II in the developing and adult human brain. J Neuropathol Exp Neurol 65: 664-674.
51. Lammel S, Hetzel A, Hackel O, Jones I, Liss B, Roeper J. 2008. Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron 57: 760-773.
52. A receptors in the ventral tegmental area control bidirectional reward signalling between dopaminergic and non-dopaminergic neural motivational systems. Eur J Neurosci 13: 1009-1015.
53. Laviolette SR, van der Kooy D. 2003. Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area. Mol Psychiatry 8: 50-59.
54. A receptors signal bidirectional reward transmission from the ventral tegmental area to the tegmental pedunculopontine nucleus as a function of opiate state. Eur J Neurosci 20: 2179-2187.
55. Laviolette SR, Alexson TO, van der Kooy D. 2002. Lesions of the tegmental pedunculopontine nucleus block the rewarding effects and reveal the aversive effects of nicotine in the ventral tegmental area. J Neurosci 22: 8653-8660.
56. A receptors in the ventral tegmental area. Nat Neurosci 7: 160-169.
57. Leitch E, Coaker J, Young C, Mehta V, Sernagor E. 2005. GABA Type-A activity controls its own developmental polarity switch in the maturing retina. J Neurosci 25: 4801-4805.
58. Le Merrer J, Becker JA, Befort K, Kieffer BL. 2009. Reward processing by the opioid system in the brain. Physiol Rev 89: 1379-1412.
59. Liu Z, Neff RA, Berg DK. 2006. Sequential interplay of nicotinic and GABAergic signaling guides neuronal development. Science 314: 1610-1613.
60. Lobo MK, Covington HE 3rd., Chaudhury D, Friedman AK, Sun H, Damez-Werno D, Dietz DM, Zaman S, Koo JW, Kennedy PJ, et al. 2010. Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 330: 385-390.
61. Lu L, Dempsey J, Liu SY, Bossert JM, Shaham Y. 2004. A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J Neurosci 24: 1604-1611.
62. B receptor agonist and antagonists decreased brain stimulation reward in the rat. Neuropharmacology 40: 676-685.
63. Madhavan A, Bonci A, Whistler JL. 2010. Opioid-induced GABA potentiation after chronic morphine attenuates the rewarding effects of opioids in the ventral tegmental area. J Neurosci 30: 14029-14035.
64. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ. 1988. Anatomy of CNS opioid receptors. Trends Neurosci 11: 308-314.
65. Margolis EB, Mitchell JM, Ishikawa J, Hjelmstad GO, Fields HL. 2008. Midbrain dopamine neurons: Projection target determines action potential duration and dopamine D2 receptor inhibition. J Neurosci 28: 8908-8913.
66. McBride WJ, Murphy JM, Ikemoto S. 1999. Localization of brain reinforcement mechanisms: Intracranial self-administration and intracranial place-conditioning studies. Behav Brain Res 101: 129-152.
67. McCarthy MM, Auger AP, Perrot-Sinal TS. 2002. Getting excited about GABA and sex differences in the brain. Trends Neurosci 25: 307-312.
68. Minami M, Satoh M. 1995. Molecular biology of the opioid receptors: Structures, functions and distributions. Neurosci Res 23: 121-145.
69. Nader K, van der Kooy D. 1994. The motivation produced by morphine and food is isomorphic: Approaches to specific motivational stimuli are learned. Psychobiology 22: 68-76.
70. Nader K, van der Kooy D. 1997. Deprivation state switches the neurobiological substrates mediating opiate reward in the ventral tegmental area. J Neurosci 17: 383-390.
71. Nader K, Bechara A, Roberts DC, van der Kooy D. 1994. Neuroleptics block high-but not low-dose heroin place preferences: Further evidence for a two-system model of motivation. Behav Neurosci 108: 1128-1138.
72. O'Brien DP, White FJ. 1987. Inhibition of non-dopamine cells in the ventral tegmental area by benzodiazepines: Relationship to A10 dopamine cell activity. Eur J Pharmacol 142: 343-354.
73. Olmstead MC, Franklin KB. 1997. The development of a conditioned place preference to morphine: Effects of microinjections into various CNS sites. Behav Neurosci 111: 1324-1334.
74. Olmstead MC, Munn EM, Franklin KB, Wise RA. 1998. Effects of pedunculopontine tegmental nucleus lesions on responding for intravenous heroin under different schedules of reinforcement. J Neurosci 18: 5035-5044.
75. Olpe HR, Koella WP, Wolf P, Haas HL. 1977. The action of baclofen on neurons of the substantia nigra and of the ventral tegmental area. Brain Res 134: 577-580.
76. Omelchenko N, Sesack SR. 2005. Laterodorsal tegmental projections to identified cell populations in the rat ventral tegmental area. J Comp Neurol 483: 217-235.
77. Omelchenko N, Sesack SR. 2007. Glutamate synaptic inputs to ventral tegmental area neurons in the rat derive primarily from subcortical sources. Neuroscience 146: 1259-1274.
78. Omelchenko N, Sesack SR. 2009. Ultrastructural analysis of local collaterals of rat ventral tegmental area neurons: GABA phenotype and synapses onto dopamine and GABA cells. Synapse 63: 895-906.
79. Omelchenko N, Sesack SR. 2010. Periaqueductal gray afferents synapse onto dopamine and GABA neurons in the rat ventral tegmental area. J Neurosci Res 88: 981-991.
80. Omelchenko N, Bell R, Sesack SR. 2009. Lateral habenula projections to dopamine and GABA neurons in the rat ventral tegmental area. Eur J Neurosci 30: 1239-1250.
81. Pettit HO, Ettenberg A, Bloom FE, Koob GF. 1984. Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology (Berl) 84: 167-173.
82. Ridderstrale Y, Wistrand PJ. 2000. Membrane-associated carbonic anhydrase activity in the brain of CA II-deficient mice. J Neurocytol 29: 263-269.
83. - co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature 397: 251-255.
84. - extrusion. J Cell Biol 159: 747-752.
85. Robinson TE, Berridge KC. 1993. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res Rev 18: 247-291.
86. Rolls ET, Rolls BJ, Kelly PH, Shaw SG, Wood RJ, Dale R. 1974. The relative attenuation of self-stimulation, eating and drinking produced by dopamine-receptor blockade. Psychopharmacology 38: 219-230.
87. Rosenblum A, Marsch LA, Joseph H, Portenoy RK. 2008. Opioids and the treatment of chronic pain: Controversies, current status, and future directions. Exp Clin Psychopharmacol 16: 405-416.
88. Rutherford LC, DeWan A, Lauer HM, Turrigiano GG. 1997. Brain-derived neurotrophic factor mediates the activity-dependent regulation of inhibition in neocortical cultures. J Neurosci 17: 4527-4535.
89. Semba K, Fibiger HC. 1992. Afferent connections of the laterodorsal and the pedunculopontine tegmental nuclei in the rat: A retro-and antero-grade transport and immunohistochemical study. J Comp Neurol 323: 387-410.
90. Sesack SR, Pickel VM. 1992. Synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol 320: 145-160.
91. Sesack SR, Pickel VM. 1995. Ultrastructural relationships between terminals immunoreactive for enkephalin, GABA, or both transmitters in the rat ventral tegmental area. Brain Res 672: 261-275.
92. Shippenberg TS, Elmer GI. 1998. The neurobiology of opiate reinforcement. Crit Rev Neurobiol 12: 267-303.
93. Spyraki C, Fibiger HC, Phillips AG. 1982. Dopaminergic substrates of amphetamine-induced place preference conditioning. Brain Res 253: 185-193.
94. - transport. J Physiol 519: 693-712.
95. A receptors. Science 269: 977-981.
96. Steffensen SC, Svingos AL, Pickel VM, Henriksen SJ. 1998. Electrophysiological characterization of GABAergic neurons in the ventral tegmental area. J Neurosci 18: 8003-8015.
97. Steffensen SC, Bradley KD, Hansen DM, Wilcox JD, Wilcox RS, Allison DW, Merrill CB, Edwards JG. 2011. The role of connexin-36 gap junctions in alcohol intoxication and consumption. Synapse 65: 695-707.
98. Stein V, Nicoll RA. 2003. GABA generates excitement. Neuron 37: 375-378.
99. Steininger TL, Rye DB, Wainer BH. 1992. Afferent projections to the cholinergic pedunculopontine tegmental nucleus and adjacent midbrain extrapyramidal area in the albino rat. I. Retrograde tracing studies. J Comp Neurol 321: 515-543.
100. Sun M-K, Alkon DL. 2001. Pharmacological enhancement of synaptic efficacy, spatial learning, and memory through carbonic anhydrase activation in rats. J Pharmacol Exp Ther 297: 961-967.
101. Sun M-K, Alkon DL. 2002. Carbonic anhydrase gating of attention: Memory therapy and enhancement. Trends Pharmacol Sci 23: 83-89.
102. Svingos AL, Garzon M, Colago EEO, Pickel VM. 2001. μ-Opioid receptors in the ventral tegmental area are targeted to presynaptically and directly modulate mesocortical projection neurons. Synapse 41: 221-229.
103. Swanson LW. 1982. The projections of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde tracer and immunofluorescence study. Brain Res Bull 9: 321-353.
104. Thierry AM, Deniau JM, Feger J. 1979. Effects of stimulation of the frontal cortex on identified output VMT cells in the rat. Neurosci Lett 15: 103-107.
105. Thierry AM, Deniau JM, Herve D, Chevalier G. 1980. Electrophysiological evidence for non-dopaminergic mesocortical and mesolimbic neurons in the rat. Brain Res 201: 210-214.
106. Thompson SM, Deisz RA, Prince DA. 1988. Outward chloride/cation co-transport in mammalian cortical neurons. Neurosci Lett 89: 49-54.
107. A receptor expression? Mol Brain Res 60: 282-290.
108. A receptors mediate the opposing roles of dopamine and the tegmental pedunculopontine nucleus in the motivational effects of ethanol. Eur J Neurosci 29: 1235-1244.
109. Ungless MA, Magill PJ, Bolam JP. 2004. Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science 303: 2040-2042.
110. Van Bockstaele EJ, Pickel VM. 1995. GABA-containing neurons in the ventral tegmental area project to the nucleus accumbens in rat brain. Brain Res 682: 215-221.
111. van Ree JM, Gerrits MA, Vanderschuren LJ. 1999. Opioids, reward and addiction: An encounter of biology, psychology, and medicine. Pharmacol Rev 51: 341-396.
112. Vargas-Perez H, Ting-A-Kee R, Walton CH, Hansen DM, Razavi R, Clarke L, Bufalino MR, Allison DW, Steffensen SC, van der Kooy D. 2009. Ventral tegmental area BDNF induces an opiate-dependent-like reward state in naive rats. Science 324: 1732-1734.
113. von Zastrow M. 2004. Opioid receptor regulation. Neuromolecular Med 5: 51-58.
114. Wagner S, Castel M, Gainer H, Yarom Y. 1997. GABA in the mammalian suprachiasmatic nucleus and its role in diurnal rhythmicity. Nature 387: 598-603.
115. Wake H, Watanabe M, Moorhouse AJ, Kanematsu T, Horibe S, Matsukawa N, Asai K, Ojika K, Hirata M, Nabekura J. 2007. Early changes in KCC2 phosphorylation in response to neuronal stress result in functional downregulation. J Neurosci 27: 1642-1650.
116. Walker BM, Ettenberg A. 2005. Intra-ventral tegmental area heroin-induced place preferences in rats are potentiated by peripherally administered alprazolam. Pharmacol Biochem Behav 82: 470-477.
117. B receptors in midbrain monoamine containing neurons in the rat. Brain Res Bull 56: 1-5.
118. Wise RA. 1989. Opiate reward: Sites and substrates. Neurosci Biobehav Rev 13: 129-133.
119. Wise RA. 1996. Neurobiology of addiction. Curr Opin Neurobiol 6: 243-251.
120. Wise RA, Rompre P-P. 1989. Brain dopamine and reward. Ann Rev Psychol 40: 191-225.
121. Wise RA, Spindler J, deWit H, Gerberg GJ. 1978. Neuroleptic-induced "anhedonia" in rats: Pimozide blocks reward quality of food. Science 201: 262-264.
122. Xia Y, Driscoll JR, Wilbrecht L, Margolis EB, Fields HL, Hjelmstad GO. 2011. Nucleus accumbens medium spiny neurons target non-dopaminergic neurons in the ventral tegmental area. J Neurosci 31: 7811-7816.
123. Yamaguchi T, Sheen W, Morales M. 2007. Glutamatergic neurons are present in the rat ventral tegmental area. Eur J Neurosci 25: 106-118.
124. Yokel RA, Wise RA. 1975. Increased lever pressing for amphetamine after pimozide in rats: Implications for a dopamine theory of reward. Science 187: 547-549.
125. Zito KA, Vickers G, Roberts DC. 1985. Disruption of cocaine and heroin self-administration following kainic acid lesions of the nucleus accumbens. Pharmacol Biochem Behav 23: 1029-1036.